Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SCO-267 by Scohia Pharma for Obesity: Likelihood of Approval
SCO-267 is under clinical development by Scohia Pharma and currently in Phase I for Obesity. According to GlobalData, Phase I...
SCO-267 by Scohia Pharma for Diabetes: Likelihood of Approval
SCO-267 is under clinical development by Scohia Pharma and currently in Phase I for Diabetes. According to GlobalData, Phase I...
SCO-267 by Scohia Pharma for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
SCO-267 is under clinical development by Scohia Pharma and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...